National Advisory Committee on Immunization
The National Advisory Committee on Immunization (NACI; French: Comité consultatif national de l'immunisation; CCNI) is an External Advisory Body that provides the Public Health Agency of Canada (PHAC) "with independent, ongoing and timely medical, scientific, and public health advice in response to questions from PHAC relating to immunization."[1] It is composed of "experts in the fields of pediatrics, infectious diseases, immunology, pharmacy, nursing, epidemiology, pharmacoeconomics, social science and public health."[2] The Committee "reports to the Vice-President of the Infectious Disease Prevention and Control Branch" of PHAC, and "works with staff of the Centre for Immunization and Respiratory Infectious Diseases" of the PHAC "to provide ongoing and timely medical, scientific and public health advice."[2]
History[edit]
NACI was established in 1964.[2]
NACI became prominent during the COVID-19 pandemic, as publisher of recommendations and guidance surrounding distribution of COVID-19 vaccines.[1][3]
Leadership[edit]
The NACI is composed of at least 14 members, roughly a dozen lobby group "liaison representatives" and roughly a dozen professional Health Canada civil servant "ex-officio representatives" support staff.[2] among whom are:
- Caroline Quach-Thanh (Chair)[4]
- Shelley Deeks (Vice-Chair)[5][4]
References[edit]
- ^ a b "Recommendations on the use of COVID-19 vaccines". Government of Canada. March 16, 2021.
- ^ a b c d "National Advisory Committee on Immunization (NACI): Membership and representation". Government of Canada. March 17, 2021.
- ^ Miller, Adam (March 30, 2021). "Why Canada is suspending use of AstraZeneca vaccine in people under 55". CBC News. Retrieved April 7, 2021. CS1 maint: discouraged parameter (link)
- ^ a b Gillies, Rob (March 29, 2021). "Canada pauses AstraZeneca vaccine for under 55". Chicago Daily Herald. Associated Press.
- ^ "Dr. Shelley Deeks". CIRN. Retrieved February 4, 2021.